• VIDO Community Liaison Committee Public Meeting

    VIDO's Community Liaison Committee invites you to attend their regular public meeting on June 22nd.

  • USask hosts the Prime Minister of Canada

    Prime Minister Justin Trudeau paid tribute to the contributions the University of Saskatchewan has made to scientific discovery, as he wrapped up his visit to campus on Wednesday.

  • A new opportunity to develop livestock and human vaccine in Saskatchewan: SARM supports VIDO‘s effort to strengthen the response to infectious disease

    The Saskatchewan Association of Rural Municipalities Board of Director’s met with VIDO in January, to discuss the ways rural municipalities can support and strengthen the world’s response to infectious diseases.

  • Developing oral vaccine for chronic wasting disease goal of funding research

    Prion disease poses significant risk to wildlife, but research into developing vaccine cause for optimism.

  • Investments in USask livestock research fuels innovation, protects animal health

    University of Saskatchewan (USask) researchers have been awarded $4.2 million to develop livestock-related innovations that range from improving forage feed to advancing work on vaccines to tackle the global spread of African swine fever (ASF).

  • Saskatoon hospital foundations offer support to USask’s VIDO

    Three of Saskatoon’s hospital foundations have partnered to donate $230,000 in support of Canada’s Centre for Pandemic Research at VIDO.

  • CEPI awards USask’s VIDO $6M for vaccine development

    VIDO at USask has received approximately CAN$6 million from the Coalition for Epidemic Preparedness Innovations. This is CEPI’s first ever award to a Canadian university.

  • The University of the Sunshine Coast leads rollout of critical vaccine for koalas

    USC is leading a Phase 3 rollout of a koala chlamydia vaccine that has been developed collaboratively over many years with many partners, including VIDO.

  • New funding will help predict SARS-CoV-2 variants and protect vulnerable populations

    VIDO scientist Dr. Alyson Kelvin was awarded close to half a million dollars to assess COVID-19 vaccine efficacy including against virus variants in vulnerable populations.

  • Alumni Ron and Jane Graham’s $5.9M gift assists vaccine research, Huskie Athletics, engineering and education students at USask

    The University of Saskatchewan’s most generous alumni, Ron and Jane Graham, are supporting the Vaccine and Infectious Disease Organization with a $1M donation.